B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

Blood. 2021 Apr 22;137(16):2267-2271. doi: 10.1182/blood.2020008609.

¹ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, University of Cologne, Cologne, Germany.
² Department II of Internal Medicine, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
³ Onkologische Schwerpunktpraxis Esslingen, Esslingen, Germany.
⁴ Servicio de Hematología, Hospital Universitario 12 de Octubre, Madrid, Spain.
⁵ Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
⁶ Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
⁷ University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
⁸ Medical Clinic III, Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, Rostock, Germany.
⁹ Department of Internal Medicine III, University of Ulm, Ulm, Germany.
¹⁰ Department of Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany; and.
¹¹ Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany.

No abstract available

Publication types